Researchers at Albert Einstein College of Medicine of Yeshiva University reported that they have developed a tuberculosis (TB) vaccine candidate that has proved both potent and safe in animal studies.
A team of U.S. and European researchers have found that a new vaccine strategy tested in mice provides stronger, more long-lasting protection from tuberculosis (TB) infection